Literature DB >> 26015376

MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1.

Qian Zhou1, Christoph Gensch2, Constanze Keller3, Hannah Schmitt3, Jennifer Esser3, Martin Moser4, James K Liao5.   

Abstract

AIMS: Angiogenesis is defined as the sprouting of capillaries from pre-existing vasculature. It is a complex process that includes endothelial proliferation, migration, and tube formation. Previous data have demonstrated a high expression level of manganese-superoxide dismutase (MnSOD) in endothelial cells and suggested an important role of MnSOD in several cardiovascular diseases. In addition, manganese (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) has been shown to mimic some of the effects of MnSOD in various tissues. However, its effect on the vasculature remains unknown. METHODS AND
RESULTS: HUVECs were treated with MnTBAP. Migration, tube formation, and capillary sprouting assays were performed to evaluate the pro-angiogenic effect in vitro. Matrigel plug assay was performed to assess capillary ingrowth in vivo. Compared to control, treatment with MnTBAP revealed increased cell migration, tube formation and capillary sprouting along with more capillary ingrowth in the Matrigel plug assay. This effect was mediated through a mitofusin (Mfn)-1-dependent pathway. Expression of Tie-2, Ang-2 and VEGF mRNA was increased in muscle tissues after ligation in MnTBAP treated mice. However, revascularization in the hindlimb ischemia model was not statistically significant at day 10 in MnTBAP treated mice.
CONCLUSION: In summary, our data demonstrate a strong pro-angiogenic, but less pro-arteriogenic effect of MnTBAP in HUVECs mediated by Mfn-1.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Endothelial cell; MnTBAP

Mesh:

Substances:

Year:  2015        PMID: 26015376      PMCID: PMC4547864          DOI: 10.1016/j.vph.2015.05.007

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  26 in total

1.  VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

2.  Factors regulating arteriogenesis.

Authors:  Wolfgang Schaper; Dimitri Scholz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-03       Impact factor: 8.311

3.  Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism.

Authors:  M R Abid; J C Tsai; K C Spokes; S S Deshpande; K Irani; W C Aird
Journal:  FASEB J       Date:  2001-09-17       Impact factor: 5.191

4.  In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro.

Authors:  Chun-Chi Liang; Ann Y Park; Jun-Lin Guan
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 5.  Functions and dysfunctions of mitochondrial dynamics.

Authors:  Scott A Detmer; David C Chan
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

6.  Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation.

Authors:  Niels van Royen; Imo Hoefer; Ivo Buschmann; Matthias Heil; Sawa Kostin; Elisabeth Deindl; Sabina Vogel; Thomas Korff; Helmut Augustin; Christoph Bode; Jan J Piek; Wolfgang Schaper
Journal:  FASEB J       Date:  2002-01-30       Impact factor: 5.191

7.  Mitochondria as signaling organelles in the vascular endothelium.

Authors:  Marisol Quintero; Sergio L Colombo; Andrew Godfrey; Salvador Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

8.  BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.

Authors:  Jennifer Heinke; Leonie Wehofsits; Qian Zhou; Christoph Zoeller; Kim-Miriam Baar; Thomas Helbing; Anna Laib; Hellmut Augustin; Christoph Bode; Cam Patterson; Martin Moser
Journal:  Circ Res       Date:  2008-09-11       Impact factor: 17.367

9.  High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice.

Authors:  Inmaculada García-Ruiz; Pablo Solís-Muñoz; Daniel Fernández-Moreira; Montserrat Grau; Francisco Colina; Teresa Muñoz-Yagüe; José A Solís-Herruzo
Journal:  Dis Model Mech       Date:  2014-09-26       Impact factor: 5.758

10.  Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice.

Authors:  Karla M Pires; Olesya Ilkun; Marina Valente; Sihem Boudina
Journal:  Obesity (Silver Spring)       Date:  2013-06-13       Impact factor: 5.002

View more
  5 in total

1.  Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.

Authors:  Lingling Si; Jianing Fu; Weiwei Liu; Toshihiko Hayashi; Yuheng Nie; Kazunori Mizuno; Shunji Hattori; Hitomi Fujisaki; Satoshi Onodera; Takashi Ikejima
Journal:  Mol Cell Biochem       Date:  2019-10-14       Impact factor: 3.396

2.  MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation.

Authors:  Qian Zhou; Michaela Einert; Hannah Schmitt; Zhengguan Wang; Franziska Pankratz; Christoph B Olivier; Christoph Bode; James K Liao; Martin Moser
Journal:  Vascul Pharmacol       Date:  2016-07-08       Impact factor: 5.773

3.  Hypoxic conditioned medium from mesenchymal stem cells promotes lymphangiogenesis by regulation of mitochondrial-related proteins.

Authors:  Chang Youn Lee; Jin Young Kang; Soyeon Lim; Onju Ham; Woochul Chang; Dae-Hyun Jang
Journal:  Stem Cell Res Ther       Date:  2016-03-11       Impact factor: 6.832

Review 4.  Mitochondria Lead the Way: Mitochondrial Dynamics and Function in Cellular Movements in Development and Disease.

Authors:  Somya Madan; Bhavin Uttekar; Sayali Chowdhary; Richa Rikhy
Journal:  Front Cell Dev Biol       Date:  2022-02-02

5.  Impact of MnTBAP and Baricitinib Treatment on Hutchinson-Gilford Progeria Fibroblasts.

Authors:  Elena Vehns; Rouven Arnold; Karima Djabali
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.